TEVA
Teva Pharmaceutical·NYSE
--
--(--)
--
--(--)
6.04 / 10
Outperform
Analyst consensus is split: 50% Strong Buy, 50% Buy, no holds. Sentiment scores 6.04/10 (Outperform). Fund‑flow rating is good (7.56), with ~46% overall inflow but negative trends across all size blocks. Price fell 8.79%, tempering optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-04
InstitutionPiper Sandler
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for TEVA?
- TEVA holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.04/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
